Folgen
-
Historical failings, like the Chinese Exclusion Act of 1882 that restricted immigration from China for 61 years, have cast a shadow of prejudice and discrimination over Asian American, Native Hawaiian, and Pacific Islander (AANHPI) populations. Its effects continue to loom heavy, often reducing these groups to a single racial-ethnic category and masking major differences that exist between them, even when it comes to their health. In this episode, Devon Valera, from the Office of NIH History, breaks down how history has shaped AANHPI experiences and perceptions, and Dr. Jacqueline Vo from the National Cancer Institute (NCI), explains why science is now calling to dismantle the myth that these populations are a monolithic group.
-
Beverly Gage came to the NIH with a condition that had never been observed before. A mysterious genetic mutation that caused her chronic joint pain and inflammation led her to Dr. Michael Ombrello, an expert in rare inflammatory diseases at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Where their paths cross shows us the current challenges of diagnosing, treating, and living with a disorder that is new to science.
-
Fehlende Folgen?
-
The blood-brain barrier keeps bad actors like toxins, viruses, and bacteria from entering the brain. But in the case of brain cancer when the danger is already inside, the blood-brain barrier can work against a person’s health by shutting out the medications meant to eliminate the threat. Dr. Sadhana Jackson from the National Institute of Neurological Disorders and Stroke (NINDS) works to figure out ways to selectively get cancer treatments through the blood-brain barrier to treat patients with certain types of brain tumors known as gliomas.
Learn more about Dr. Jackson work at https://irp.nih.gov/pi/sadhana-jackson.
-
Epidemiologists are the watchful guardians of public health. They collect and analyze data to track the status quo. When there are deviations, they crunch the numbers to understand who is getting sick, where, how, and why. Dr. Meredith Shiels is an epidemiologist and senior investigator at the National Cancer Institute (NCI) studying cancer mortality rates to discern what populations might be at higher risk, figure out ways to mitigate those risks, and evaluate whether those measures are working.
Learn more about Dr. Shiels’s research at https://irp.nih.gov/pi/meredith-shiels.
-
Despite negative consequences and the desire to stop, millions of people with compulsive behaviors can’t break the self-destructive cycles that disrupt their daily lives. Dr. Veronica Alvarez and Dr. Bruno Averbeck from the National Institute of Mental Health run the Center on Compulsive Behaviors (CCB) which brings together NIH scientists to understand what drives these repetitive and often detrimental behaviors. The CCB strives to decipher the neural circuitry that leads to compulsive behaviors in hopes of improving treatments and designing new interventions.
Learn more about the CCB at https://research.ninds.nih.gov/researchers/center-compulsive-behaviors-ccb.
-
Sugars, also referred to as carbohydrates, aren’t just substances we add to make coffee taste less bitter or food sweeter; they are an entire class of molecules necessary for life. The study of these carbohydrates is called glycobiology. Dr. John Hanover is a glycobiologist and the chief of the laboratory of cell and molecular biology at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). His work is advancing scientists’ understanding of the sugar structures responsible for rare diseases and genetic transgenerational inheritance.
-
None of the groundbreaking research taking place in the IRP would be possible with the hard work and dedication of trainees. While they work to support the NIH’s mission to turn discovery into health, the Office of Intramural Training and Education (OITE) works to supports trainees in their professional pursuits. Dr. Sharon Milgram is the director of OITE and a strong proponent that good training begets good science. In this episode, she talks about the many ways OITE supports students and fellows so that they can achieve their best work and make the most of their experience in the IRP.
-
For Dr. Steve Holland, the mystery of why some people are more prone to disease is as much a curiosity as it is a calling. Dr. Holland is the scientific director and chief of the immunopathogenesis section at the National Institute of Allergy and Infectious Diseases (NIAID) where he searches for signs to explain differences in susceptibility to certain infections. In this episode, he discusses how the immune system can thwart its own defenses by producing antibodies that block the chemical signals it needs to put up a fight.
-
NASA recently unveiled the first images taken by the James Webb Telescope. But the distant cosmos aren't the only ones coming into focus. While astronomers point their instruments up to peer into the stars, microscopists like Dr. Hari Shroff are focusing their gaze down to capture life on Earth. As chief of the Section on High Resolution Optical Imaging at the National Institute of Biomedical Imaging and Bioengineering (NIBIB), Dr. Shroff engineers new microscopes to render the invisibly small in new and improved resolution.
-
Finding treatments for mental health conditions doesn't just deal with people who live with them. Healthy volunteers play a critical part in the science of understanding our brains and behavior. But what qualifies as "healthy" can vary across labs and skew how scientists interpret study results. Dr. Joyce Chung, the Deputy Clinical Director at the National Institute of Mental Health (NIMH), is changing that. She is creating a pool of vetted volunteers to bolster the integrity, efficiency, and safety of mental health research.
-
Science is receptive to new information that can refine the theories we use to make sense of the world. Such is the case with Dr. Lauren Porter, a Stadtman investigator at the National Library of Medicine who is helping redefine the way we understand how proteins behave. She is looking at a new class of proteins that can change their structure and function much like the famous Transformer robots that morph into different machines. Understanding how these proteins switch their shape could help scientists understand the molecular basis of certain diseases like cancer and Alzheimer’s.
-
Centuries of selective breeding have given rise to a staggering variety of dog breeds, each with its own traits and behaviors. But shallow gene pools have also put some breeds at higher risk for disease. Dr. Elaine Ostrander runs the Dog Genome Project at the National Human Genome Research Institute. Her team includes Dr. Heidi Parker. Together, they are digging for clues to understand how genes code for dogs' diversity and disease. Clues that might also inform the health of their two-legged caregivers.
-
The annual flu vaccine is the best way to prevent yourself and others from getting sick. But sometimes the antigens the vaccine trains your body to fight are not similar enough to the strains of influenza circulating that year. This mismatch allows viruses to fly under the radar and spread undetected. It's a problem scientists hope to solve with a universal flu vaccine. Dr. Matthew Memoli is an influenza expert at the National Institute of Allergy and Infectious Diseases (NIAID). He is preparing to test a new vaccine candidate that could offer protection from more flu strains and for more people.
-
There is more to color than meets the eye. According to Dr. Bevil Conway, how we perceive color can inform how our brains receive, interpret, and generate knowledge about the world. Dr. Conway is a visual artist and a neuroscientist at the National Eye Institute. He is working to decode the neural basis of color. In a recent study, his lab mapped how different colors can stimulate different patterns of brain activity.
-
The success of mRNA vaccines against the coronavirus that causes COVID-19, has brought RNA biology into the limelight. Now, with the world's attention, what's next for this biomedical rising star? NIH scientists, Dr. Richard Maraia and Dr. Natasha Caplen, have long recognized the potential of RNA in improving human health. In this episode, they discuss the prospects of RNA biology and how their work could inform the future of RNA as an innovative class of medicine.
-
When the COVID-19 pandemic struck, racial and ethnic minority groups were disproportionately hit. The health inequities pulled at the seams of a system that was already frayed. Dr. Anna Nápoles works to close gaps in healthcare as the first Latina scientific director of the National Institute on Minority Health and Health Disparities (NIMHD). She is reducing the types of hurdles that once hindered her parents so that all populations can live long, healthy, and productive lives.
Learn more about Dr. Nápoles's research at https://irp.nih.gov/pi/anna-napoles.
-
Pregnancy is by no means necessary for motherhood, but it is necessary for life. And it's no picnic. A pregnant person can experience complications like anemia, UTIs, hypertension, diabetes, and exhaustion. Maintaining maternal health during pregnancy can be challenging, but it is integral for the health of the fetus. Dr. Diana Bianchi is a physician-scientist and the director of the National Institute of Child Health and Human Development (NICHD), where she works to improve care for the mommy-baby unit.
Learn more about her research at https://irp.nih.gov/pi/diana-bianchi.
-
Small errors can quickly escalate to have large repercussions. When it comes to cancer, molecular changes to DNA can trigger chain reactions that cause cells to go awry and spread uncontrollably. Dr. Louis Staudt works to identify such changes, known as genetic mutations, and find ways to stop them from snowballing into a deadly disease. In this episode, Dr. Staudt recounts the story of how he differentiated subtypes of lymphomas to develop a treatment for patients as an early success of precision medicine.
Dr. Staudt is a principle investigator and the director of the Center for Cancer Genomics at the National Cancer Institute. He was recently elected into the National Academy of Medicine. Learn more about his research at https://irp.nih.gov/pi/louis-staudt.
-
Nutrition is a contentious topic. It’s hard to tell fact from fiction. One day eggs are good for you, the next they have too much fat. But what about the keto craze? Doesn’t it say you should eat mostly fats? Fortunately, there are scientist like Dr. Kevin Hall who are working to debunk the myths and give us the real skinny on how the foods we eat affect our health. Most recently, Dr. Hall published a study that put two well-known diets head-to-head to see which led people to consume more calories.
-
Ketamine is often thought of as an illicit party drug—something people take for a momentary high. But it wasn’t designed to be a mind-altering drug. Originally, ketamine was developed as anesthetic to relieve temporary pain. And now it seems the drug can provide solace not just from physical distress. At the NIH, Dr. Carlos Zarate is investigating how ketamine can rapidly reduce depressive symptoms in people with treatment-resistant depression or bipolar depression, for whom other options have not helped.
- Mehr anzeigen
